flp-11 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Specificity

The flp-11 antibody detects FLP-11 peptides, which are part of the FMRFamide-like peptide (FLP) family in nematodes. These peptides share a C-terminal Arg-Phe-NH2 motif and are involved in neuromodulation, including motor function regulation . FLP-11 peptides include AMRNALVRFG, (A)S(G)GMRNALVRFG, and NGAPQPFVRFG, with structural conservation across species like Caenorhabditis elegans and Ascaris suum .

Table 1: Expression of flp-11 Across Nematode Species

SpeciesExpression ProfileConservationSource
C. elegansHead muscle, pharyngeal muscle, vulval/uterine cells, and limited neurons High
A. suumRestricted to the RIS neuronModerate
Haemonchus contortusCo-expressed with flp-32; broader neuronal distribution than C. elegansLow

Key findings:

  • flp-11 expression is restricted compared to flp-32 in species expressing both genes .

  • In species lacking flp-32, flp-11 adopts a broader expression pattern resembling flp-32 .

Table 2: Functional Roles of FLP-11 Peptides

FunctionExperimental EvidenceSource
Motor inhibitionFLP-11 peptides reduce locomotion in C. elegans and parasitic nematodes
NeuromodulationCo-localizes with cholinergic neurons, suggesting cross-talk with acetylcholine
Non-neuronal rolesExpressed in uterine and vulval cells, implicating roles in reproduction

Antibody Development Challenges

  • Specificity Issues: FLP-11 antibodies may cross-react with structurally similar FLPs due to shared C-terminal motifs .

  • Technical Limitations: Early immunocytochemistry studies underestimated flp-11 expression due to antibody specificity constraints .

Applications in Research

  • Immunocytochemistry (ICC): Maps FLP-11 peptide distribution in tissues .

  • Behavioral Assays: Links FLP-11 to motor inhibition via peptide injection or RNAi .

  • Evolutionary Studies: Compares flp-11 expression across clades to infer functional conservation .

Key Research Findings

  1. Motor Regulation: FLP-11 peptides inhibit locomotion in parasitic nematodes, suggesting therapeutic potential .

  2. Species-Specific Adaptations: flp-11 expression in C. elegans is less widespread than previously reported, contrasting with parasitic species .

  3. Non-Neuronal Roles: FLP-11 influences uterine and vulval development in C. elegans .

Future Directions

  • Develop isoform-specific antibodies to distinguish FLP-11 peptides .

  • Explore FLP-11 as a target for anthelmintic drugs leveraging its motor-inhibitory effects .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
flp-11 antibody; K02G10.4FMRFamide-like neuropeptides 11 [Cleaved into: AMRNALVRF-amide; ASGGMRNALVRF-amide; SPLDEEDFAPESPLQ-amide; NGAPQPFVRF-amide] antibody
Target Names
flp-11
Uniprot No.

Target Background

Function

FMRFamides and FMRFamide-like peptides are neuropeptides. This antibody targets a peptide with potent inhibitory effects on the dissected pharyngeal myogenic muscle system. In vitro studies demonstrate its function as a ligand for the npr-22 receptor.

Gene References Into Functions

Relevant research highlights the role of FLP-11 in neuronal modulation:

  1. Studies have shown that peptides encoded by the nlp-7 and flp-11 genes, produced by uv1 cells, modulate circuit activity through local inhibition of vesicular serotonin release from HSN motor neurons. (PMID: 28384151)
  2. Upon sleep onset, RIS depolarization triggers FLP-11 release, initiating a systemic sleep state. (PMID: 26949257)
Database Links

KEGG: cel:CELE_K02G10.4

STRING: 6239.K02G10.4a

UniGene: Cel.817

Protein Families
FARP (FMRFamide related peptide) family
Subcellular Location
Secreted.
Tissue Specificity
Each flp gene is expressed in a distinct set of neurons. Flp-11 is expressed in the DD, VD and DVB motor neurons, the PVC and URX interneurons, and the AUA, BAG, DA, LUA, and SAB neurons. Also expressed in head muscle, socket or sheath cells and uterine c

Q&A

What is flp-11 and why is it significant in nematode research?

flp-11 is a FMRFamide-like peptide encoding gene found across multiple nematode species. Its significance stems from its role in encoding neuropeptides that inhibit motor function in nematodes. It represents one of the most interesting examples of peptide encoding in nematodes because it shares the ability to encode the peptide AMRN(A/S)LVRFamide with another distinct gene, flp-32 – the only known example of this phenomenon within the FLPergic system of nematodes . Understanding flp-11 biology is crucial for researchers exploring nematode neurobiology, parasite control mechanisms, and comparative genomics.

What is the structural relationship between FLP-11 and FLP-32 peptides?

FLP-11 and FLP-32 peptides share highly similar sequences, with both encoding the analogous peptide AMRN(A/S)LVRFamide in multiple nematode species . In C. elegans and Ascaris suum, flp-11 encodes three VRFamide peptides: AMRNALVRFG, (A)S(G)GMRNALVRFG, and NGAPQPFVRFG . This structural similarity creates significant challenges for antibody development and experimental design, as researchers must ensure their antibodies can differentiate between these similar peptides when needed.

Which techniques are commonly used for detecting flp-11 expression in nematodes?

Common techniques for studying flp-11 expression include:

  • In situ hybridization (ISH) - for detecting flp-11 mRNA in tissue samples

  • Immunocytochemistry (ICC) - for visualizing FLP-11 peptides using specific antibodies

  • PCR and RACE PCR - for identifying and characterizing flp-11 genes using degenerate primers and gene-specific primers

  • Bioinformatics analysis - for identifying putative flp-11 sequences in genomic and transcriptomic datasets

When selecting antibodies for ICC, researchers must consider cross-reactivity with FLP-32 peptides due to their sequence similarity.

How can researchers distinguish between flp-11 and flp-32 expression when using antibodies?

This represents one of the most challenging aspects of FLP research in nematodes. To distinguish between flp-11 and flp-32 expression:

  • Use combined approaches with mRNA detection (such as ISH with gene-specific probes) alongside antibody detection

  • Design antibodies against unique regions of the prepropeptides rather than the mature peptides

  • Validate antibody specificity using knockout or knockdown models for either flp-11 or flp-32

  • Perform parallel experiments in species known to express only flp-11 or that have documented expression patterns

  • Analyze the distinct spatial expression patterns, as flp-11 typically shows restricted expression while flp-32 is more widespread in dual-expressing species

What considerations are necessary when developing antibodies against FLP-11 peptides?

When developing antibodies against FLP-11 peptides, researchers should consider:

  • Epitope selection - target unique regions outside the AMRN(A/S)LVRFamide sequence to avoid cross-reactivity with FLP-32

  • Validation across species - confirm specificity in multiple nematode species, especially those with known expression patterns

  • Pre-absorption controls - use synthetic FLP-11 and FLP-32 peptides to test antibody specificity

  • C-terminal amidation - ensure antibodies can recognize the amidated C-terminus critical for biological activity

  • Post-translational modifications - consider how these might affect epitope recognition

The significant overlap in peptide sequences makes developing truly specific antibodies technically challenging but essential for accurate research outcomes.

How does the flp-11/flp-32 dichotomy impact antibody selection for comparative studies across nematode species?

The flp-11/flp-32 dichotomy creates significant challenges for comparative studies. Researchers should:

  • Determine whether target species express flp-11, flp-32, or both before selecting antibodies

  • Consider using species-specific antibodies when working across multiple nematode clades

  • Implement complementary techniques (qPCR, ISH) to validate antibody-based findings

  • Account for expression pattern differences - flp-11 has restricted expression in dual-expressing species but wider expression in flp-32-lacking species

  • Design experiments to account for functional redundancy between the peptides

This dichotomy necessitates careful experimental design and interpretation, particularly when translating findings across different nematode species.

What are the implications of FLP-11 peptides' inhibitory effect on motor function for experimental design?

The inhibitory effect of FLP-11 peptides on motor function in multiple nematode species has several implications for experimental design:

  • Physiological assays measuring movement or muscle contraction must account for endogenous FLP-11 activity

  • When using antibodies to block FLP-11 function, researchers must monitor for compensatory mechanisms through FLP-32

  • Behavioral assays should be designed to detect subtle changes in motor function following manipulation of FLP-11 levels

  • Time-course studies may be necessary as the inhibitory effects could vary temporally

  • Controls must include specificity tests to ensure observed effects are due to FLP-11 manipulation rather than off-target effects

Understanding this inhibitory function provides context for interpreting experimental outcomes in neuromuscular studies.

What immunocytochemistry protocols are most effective for FLP-11 detection in nematode tissues?

For effective FLP-11 detection using immunocytochemistry:

  • Fixation: 4% paraformaldehyde is typically effective for neuropeptide preservation

  • Permeabilization: Use 0.1-0.5% Triton X-100, with duration optimized for species and tissue type

  • Blocking: 5-10% normal serum matching the secondary antibody host species

  • Primary antibody: Incubate with anti-FLP-11 at optimized dilution (typically 1:500-1:2000) for 12-48 hours at 4°C

  • Secondary antibody: Fluorophore-conjugated antibodies similar to those used for TNF-alpha detection can be adapted, using similar parameters (≤1 μg per test)

  • Controls: Include absorption controls with synthetic FLP-11 peptides and negative controls omitting primary antibody

  • Counterstaining: DAPI for nuclei and additional neural markers to provide context for FLP-11 localization

These protocols require optimization for different nematode species due to variable tissue penetration and fixation requirements.

How can researchers validate flp-11 antibody specificity given the similarity to flp-32 peptides?

To validate antibody specificity:

  • Peptide competition assays: Pre-incubate antibodies with synthetic FLP-11 and FLP-32 peptides to confirm specificity

  • Western blot analysis: Verify antibody binding to proteins of expected molecular weight

  • Knockout/knockdown validation: Test antibodies in flp-11 null/knockdown models to confirm signal reduction

  • Cross-species validation: Test in species that express only flp-11 or flp-32

  • Parallel mRNA detection: Correlate antibody staining with in situ hybridization using gene-specific probes

  • Mass spectrometry validation: Confirm peptide identity in immunoprecipitated samples

Validation MethodAdvantagesLimitations
Peptide competitionDirect test of epitope bindingCannot rule out all cross-reactivity
Western blotConfirms size-appropriate bindingMay miss post-translational modifications
Knockout validationGold standard for specificityNot available for all species
Cross-species testingTests real-world applicationMay be affected by evolutionary differences
mRNA correlationIndependent validation approachCannot confirm protein translation/stability
Mass spectrometryDefinitive peptide identificationTechnically challenging, requires specialized equipment

What are the most effective expression systems for generating flp-11 antibodies?

For generating effective flp-11 antibodies:

  • Peptide-carrier conjugation: Synthetic FLP-11 peptides conjugated to KLH or BSA carriers represent the most direct approach

  • Recombinant expression: The Flp-In system can be adapted for consistent expression of FLP-11 peptide fragments in mammalian cells

  • Genetic immunization: DNA vaccines encoding unique regions of the FLP-11 prepropeptide

  • Phage display: For developing high-affinity monoclonal antibodies with defined specificity

When selecting an expression system, consider:

  • The need for post-translational modifications (particularly C-terminal amidation)

  • Epitope accessibility and immunogenicity

  • Required antibody format (polyclonal vs. monoclonal)

  • Cross-reactivity concerns with FLP-32 peptides

How does sample preparation affect flp-11 antibody performance in different nematode species?

Sample preparation significantly impacts antibody performance across nematode species:

  • Fixation timing: Rapid fixation is critical to prevent neuropeptide degradation by endogenous proteases

  • Fixative selection: Paraformaldehyde preserves peptide structure while maintaining tissue morphology

  • Permeabilization: Varies by cuticle thickness and composition across species; more robust species may require longer detergent treatment

  • Antigen retrieval: May be necessary for some species but can damage epitopes if excessive

  • Blocking parameters: Higher concentrations (5-10%) of normal serum may be required for species with higher background

  • Incubation times: Longer primary antibody incubations (24-48 hours) improve penetration in larger nematodes

Researchers should optimize protocols for each species, considering morphological differences that affect antibody penetration and epitope accessibility.

How can flp-11 antibodies be used to investigate neuropeptide function in behavioral studies?

flp-11 antibodies can enhance behavioral studies through:

  • Correlative analysis: Map FLP-11 expression patterns in specimens exhibiting specific behavioral phenotypes

  • Functional blocking: Use antibodies to neutralize FLP-11 peptides in vivo and observe effects on motor function

  • Activity-dependent labeling: Combine with activity markers to identify when FLP-11-expressing neurons are activated during specific behaviors

  • Comparative neuroanatomy: Compare FLP-11 distribution across species with different behavioral adaptations

  • Developmental timing: Track FLP-11 expression throughout development to correlate with the emergence of specific behaviors

Since FLP-11 peptides inhibit motor function across multiple nematode species , antibodies can help elucidate the mechanism and timing of this inhibition in relation to behavioral outputs.

What approaches can be used to study flp-11 and flp-32 co-expression using antibodies?

To study co-expression of flp-11 and flp-32:

  • Double labeling: Use antibodies raised against unique regions of each prepropeptide

  • Sequential staining: When antibodies are from the same host species, employ sequential staining protocols with blocking steps between

  • Dual ISH/ICC: Combine in situ hybridization for one gene with immunocytochemistry for the other protein

  • Single-cell resolution techniques: Employ confocal microscopy with deconvolution for accurate co-localization analysis

  • Fluorescence resonance energy transfer (FRET): If peptides interact, FRET-based approaches with labeled antibodies can detect close association

The confined expression of flp-11 compared to the more widespread expression of flp-32 in dual-expressing species creates both challenges and opportunities for studying their potential functional interactions.

How can quantitative analysis be performed with flp-11 antibodies in comparative studies?

For quantitative analysis with flp-11 antibodies:

  • Standardized immunostaining: Maintain identical protocols, antibody concentrations, and incubation times across all samples

  • Fluorescence calibration: Use calibration standards in each experiment to normalize signal intensity

  • Automated image analysis: Develop consistent thresholding parameters for signal detection

  • Reference markers: Include internal standards (e.g., housekeeping proteins) for normalization

  • Statistical approaches: Account for species-specific background and autofluorescence

What are common pitfalls when using flp-11 antibodies, and how can they be addressed?

Common pitfalls and solutions:

  • Cross-reactivity with FLP-32: Use peptide competition assays to determine specificity; validate with gene-specific approaches

  • Variable penetration: Optimize permeabilization for each species; consider sectioning thicker specimens

  • Fixation artifacts: Test multiple fixation protocols; compare with in vivo imaging when possible

  • Background signal: Increase blocking duration and concentration; add bovine serum albumin to reduce non-specific binding

  • Signal variability: Standardize tissue handling times to prevent peptide degradation

  • False negatives: Confirm antibody reactivity with positive controls; consider epitope masking due to protein interactions

Understanding the specific expression pattern of flp-11 (restricted in dual-expressing species but wider in species expressing only flp-11) can help distinguish true signal from artifacts.

How should researchers interpret apparently conflicting flp-11 antibody results across different nematode species?

When interpreting conflicting results:

  • Consider evolutionary differences: Expression patterns may genuinely differ between species

  • Examine methodological variations: Differences in fixation, permeabilization, or antibody concentration

  • Account for developmental timing: Expression may vary across life stages

  • Evaluate antibody specificity: Confirm antibodies recognize homologous epitopes across species

  • Consider compensatory mechanisms: In species lacking flp-32, flp-11 may adopt broader expression patterns

  • Examine environmental influences: Neuropeptide expression can respond to environmental conditions

The established pattern that flp-11 has restricted expression in species with both flp-11 and flp-32, but wider expression in species with only flp-11 , provides a framework for interpreting apparent inconsistencies.

How can new antibody technologies advance our understanding of flp-11/flp-32 dynamics?

Emerging antibody technologies offer new approaches:

  • Single-domain antibodies (nanobodies): Smaller size allows better tissue penetration and potentially higher specificity

  • Recombinant antibody fragments: Can be engineered for enhanced specificity to unique regions of FLP-11

  • Intrabodies: Genetically encoded antibodies expressed within cells could track FLP-11 in vivo

  • Bifunctional antibodies: Target both FLP-11 and potential interaction partners

  • Photoswitchable antibodies: Enable super-resolution microscopy for nanoscale localization

These technologies may help resolve the persistent challenge of distinguishing between the highly similar peptides encoded by flp-11 and flp-32 genes in nematode research.

What research questions about flp-11 remain unanswered that new antibody approaches could address?

Key unanswered questions include:

  • How do FLP-11 peptides interact with their receptors at the molecular level?

  • Do FLP-11 and FLP-32 peptides serve redundant or complementary functions in species expressing both?

  • What mechanisms regulate the differential expression of flp-11 in different nematode species?

  • How do environmental factors influence FLP-11 expression and function?

  • What role does FLP-11 play in parasite-host interactions across different nematode parasites?

Antibody-based approaches, particularly when combined with genetic and electrophysiological methods, can help address these fundamental questions about neuropeptide function in nematodes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.